An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
Bossini-Castillo, Lara; Campillo-Davó, Diana; López-Isac, Elena; Carmona, Francisco David; Simeon, Carmen P; Carreira, Patricia; Callejas-Rubio, José Luis; Castellví, Iván; Fernández-Nebro, Antonio; Rodríguez-Rodríguez, Luis; Rubio-Rivas, Manel; García-Hernández, Francisco J; Madroñero, Ana Belén; Beretta, Lorenzo; Santaniello, Alessandro; Lunardi, Claudio; Airó, Paolo; Hoffmann-Vold, Anna-Maria; Kreuter, Alexander; Riemekasten, Gabriela; Witte, Torsten; Hunzelmann, Nicolas; Vonk, Madelon C; Voskuyl, Alexandre E; de Vries-Bouwstra, J; Shiels, Paul; Herrick, Ariane; Worthington, Jane; Radstake, Timothy R D J; Martin, Javier.
; 44(10): 1453-1457, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28668810
Extension of the survival dimensionality reduction algorithm to detect epistasis in competing risks models (SDR-CR).
Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease.
Brief Report: Whole-Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis.
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.
[Kidneys in diffuse systemic sclerosis].
STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.
Identification of a novel HLA-DPB1 allele, DPB1*131:01, by sequence-based typing.
Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
Toward personalized medicine in scleroderma: classification of scleroderma patients into stable "inflammatory" and "fibrotic" subgroups.